Multiparametric-MRI in diagnosis of prostate cancer.
Multiparametric-MRI in diagnosis of prostate cancer.
复制标题
DOI：
10.4103/0970-1591.159606
复制
发表时间：
2015-07
期刊：
影响因子：
--
通讯作者：
Haider MA
中科院分区：
文献类型：
--
作者：
Ghai S;Haider MA
多参数磁共振成像（mp-MRI）在诊断、定位、风险分层和临床显著前列腺癌分期方面显示出有希望的结果。它还为前列腺癌的重点治疗开辟了机会。T2加权成像、扩散成像、灌注（动态对比增强成像）和光谱成像的组合已用于前列腺癌的mp-MRI评估，但通过扩散成像进行的T2形态评估和功能评估仍然是mp-MRI前列腺癌诊断的主要方法。由于mp-MRI的评估可能是主观的，因此使用新开发的标准化报告前列腺成像和报告前列腺数据系统评分系统和专业放射科医生的教育对于准确解读至关重要。本文综述了mp-MRI在前列腺癌中的现状及其在前列腺癌治疗中的作用。
Multiparametric-magnetic resonance imaging (mp-MRI) has shown promising results in diagnosis, localization, risk stratification and staging of clinically significant prostate cancer. It has also opened up opportunities for focal treatment of prostate cancer. Combinations of T2-weighted imaging, diffusion imaging, perfusion (dynamic contrast-enhanced imaging) and spectroscopic imaging have been used in mp-MRI assessment of prostate cancer, but T2 morphologic assessment and functional assessment by diffusion imaging remains the mainstay for prostate cancer diagnosis on mp-MRI. Because assessment on mp-MRI can be subjective, use of the newly developed standardized reporting Prostate Imaging and Reporting Archiving Data System scoring system and education of specialist radiologists are essential for accurate interpretation. This review focuses on the present status of mp-MRI in prostate cancer and its evolving role in the management of prostate cancer.